Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor

Microbiological Research

Volumn 164, Issue 3, 2009, Pages 338-346

  Balakrishnan, Amit ^a,b,c   Wang, Lingling ^a   Li, Xiaojin ^a   Ohman Strickland, Pamela ^d   Malatesta, Paul ^a   Fan, Huizhou ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d University of Medicine and Dentistry   (United States)

Author keywords

Chlamydia; GM6001; Peptide deformylase; Sexually transmitted infection; Topical microbicide

Indexed keywords

AMINES; CELL CULTURE; PROBABILITY DISTRIBUTIONS;

CHLAMYDIA; GM6001; PEPTIDE DEFORMYLASE; SEXUALLY TRANSMITTED INFECTION; TOPICAL MICROBICIDE;

POLYPEPTIDES;

BACTERIAL DISEASE; BACTERIUM; ENZYME ACTIVITY; FEMALE; INHIBITION; PROBIOTICS; REPRODUCTIVE DISORDER; RODENT; SEXUALLY TRANSMITTED DISEASE;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; LACTOBACILLUS PLANTARUM; MURINAE; MUS;

EID: 65549129692     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2007.05.002     Document Type: Article

References (43)

1. Achilles S.L., Shete P.B., Whaley K.J., Moench T.R., and Cone R.A. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 29 (2002) 655-664
2. Antonio M.A., Rabe L.K., and Hillier S.L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 192 (2005) 394-398
3. Balakrishnan A., Patel B., Sieber S.A., Chen D., Pachikara N., Zhong G., et al. Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen chlamydia trachomatis by targeting peptide deformylase of the bacterium. J Biol Chem 281 (2006) 16691-16699
4. Ballweber L.M., Jaynes J.E., Stamm W.E., and Lampe M.F. In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother 46 (2002) 34-41
5. Barron A.L., White H.J., Rank R.G., Soloff B.L., and Moses E.B. A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J Infect Dis 143 (1981) 63-66
6. Bonetti A., Morelli L., Campominosi E., Ganora E., and Sforza F. Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus Doderlein's bacillus in tablet formulation to vaginal epithelial cells. Minerva Ginecol 55 (2003) 279-287
7. Bourne N., Zaneveld L.J., Ward J.A., Ireland J.P., and Stanberry L.R. Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice. Clin Microbiol Infect 9 (2003) 816-822
8. Chen D., and Yuan Z. Therapeutic potential of peptide deformylase inhibitors. Expert Opin Invest Drugs 14 (2005) 1107-1116
9. Chen D.Z., Patel D.V., Hackbarth C.J., Wang W., Dreyer G., Young D.C., et al. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry 39 (2000) 1256-1262
10. de la Maza L., Pal S., Khamesipour A., and Peterson E. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immunol 62 (1994) 2094-2097
11. Dean C.R., Narayan S., Daigle D.M., Dzink-Fox J.L., Puyang X., Bracken K.R., et al. Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. Antimicrob Agents Chemother 49 (2005) 3129-3135
12. Eisenberg M.E. The association of campus resources for gay, lesbian, and bisexual students with college students' condom use. J Am Coll Health 51 (2002) 109-116
13. Fan H. Thymidylate synthesis and folate metabolism by the obligate intracellular parasite chlamydiae - metabolic studies and molecular cloning. Winnipeg: Department of Medical Microbiology. University of Manitoba; 1994. p. 1-154.
14. Fan H., Brunham R.C., and McClarty G. Acquisition and synthesis of folates by obligate intracellular bacteria of the genus Chlamydia. J Clin Invest 90 (1992) 1803-1811
15. Feehan C., Darlak K., Kahn J., Walcheck B., Spatola A.F., and Kishimoto T.K. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. Identification with an L-selectin-alkaline phosphatase reporter. J Biol Chem 271 (1996) 7019-7024
16. Frick K.D., Colchero M.A., and Dean D. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis. Vaccine 22 (2004) 689-696
17. Greene W., Xiao Y., Huang Y., McClarty G., and Zhong G. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immunol 72 (2004) 451-460
18. Gulati S., Ngampasutadol J., Yamasaki R., McQuillen D.P., and Rice P.A. Strategies for mimicking neisserial saccharide epitopes as vaccines. Int Rev Immunol 20 (2001) 229-250
19. Holt B.Y., Morwitz V.G., Ngo L., Harrison P.F., Whaley K.J., Pettifor A., et al. Microbicide preference among young women in California. J Womens Health (Larchmt) 15 (2006) 281-294
20. Imtiaz M.T., Schripsema J.H., Sigar I.M., Kasimos J.N., and Ramsey K.H. Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infect Immunol 74 (2006) 5513-5521
21. Jerse A.E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immunol 67 (1999) 5699-5708
22. Jones R.N., Moet G.J., Sader H.S., and Fritsche T.R. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J Antimicrob Chemother 53 (2004) 804-807
23. Kilic E., Aslim B., and Taner Z. Susceptibility to some antifungal drugs of vaginal lactobacilli isolated from healthy women. Drug Metabol Drug Interact 21 (2005) 67-74
24. Knight S.T., Lee S.H., Davis C.H., Moorman D.R., Hodinka R.L., and Wyrick P.B. In vitro activity of nonoxynol-9 on McCoy cells infected with Chlamydia trachomatis. Sex Transm Dis 14 (1987) 165-173
25. Kreusch A., Spraggon G., Lee C.C., Klock H., McMullan D., Ng K., et al. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase. J Mol Biol 330 (2003) 309-321
26. Lampe M.F., Ballweber L.M., and Stamm W.E. Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel. Antimicrob Agents Chemother 42 (1998) 1726-1730
27. Levy D.E., Lapierre F., Liang W., Ye W., Lange C.W., Li X., et al. Matrix metalloproteinase inhibitors: a structure-activity study. J Med Chem 41 (1998) 199-223
28. Li X., and Fan H. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-{alpha} converting enzyme (TACE). J Biol Chem 279 (2004) 27365-27375
29. Littell R.C., Milliken G.A., Stroup W.W., and Wolfinger R.D. SAS system for mixed models (1996), SAS Institute Inc., Cary, NC
30. Matijevic-Sosa J., and Cvetnic Z. Antimicrobial activity of N-phthaloylamino acid hydroxamates. Acta Pharm 55 (2005) 387-399
31. Ramsey K.H., Sigar I.M., Schripsema J.H., Shaba N., and Cohoon K.P. Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect Immunol 73 (2005) 6962-6973
32. Ronnqvist P.D., Forsgren-Brusk U.B., and Grahn-Hakansson E.E. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand 85 (2006) 726-735
33. SAS Institute Inc. SAS® user's guide, Version 8. Cary, NC: SAS Institute, Inc.; 1999.
34. Schachter J. Infection and disease epidemiology. In: Stephens R.S. (Ed). Chlamydia intracellular biology, pathogenesis (1999), ASM Press, Washington, DC 139-169
35. Schultz G.S., Strelow S., Stern G.A., Chegini N., Grant M.B., Galardy R.E., et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci 33 (1992) 3325-3331
36. Sha B.E., Zariffard M.R., Wang Q.J., Chen H.Y., Bremer J., Cohen M.H., et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 191 (2005) 25-32
37. Shi L., Nishioka W.K., Th'ng J., Bradbury E.M., Litchfield D.W., and Greenberg A.H. Premature p34cdc2 activation required for apoptosis. Science 263 (1994) 1143-1145
38. Stamm W.E., Handsfield H.H., Rompalo A.M., Ashley R.L., Roberts P.L., and Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260 (1988) 1429-1433
39. Vallor A.C., Antonio M.A., Hawes S.E., and Hillier S.L. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis 184 (2001) 1431-1436
40. Williams D., and Churchill D. Ulcerative proctitis in men who have sex with men: an emerging outbreak. BMJ 332 (2006) 99-100
41. Xiao Y., Zhong Y., Greene W., Dong F., and Zhong G. Chlamydia trachomatis infection inhibits both bax and bak activation induced by staurosporine. Infect Immunol 72 (2004) 5470-5474
42. Yang H., Li X., Stanton B., Fang X., Lin D., Mao R., et al. Workplace and HIV-related sexual behaviours and perceptions among female migrant workers. AIDS Care 17 (2005) 819-833
43. Yuan Z., and White R.J. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics. Biochem Pharmacol 71 (2006) 1042-1047